Balance of GAD65-specific IL-10 production and polyclonal Th1-type response in type 1 diabetes

Autoimmunity

Volumn 34, Issue 1, 2001, Pages 45-52

  Funae, O ^a   Shimada, A ^a   Tokui, M ^a   Takei, I ^a   Saruta, T ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

GAD; NOD mouse; Th1 Th2; Type 1 diabetes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; INTERLEUKIN 10; MONOCLONAL ANTIBODY CD3; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON PRODUCTION; MOUSE; NONHUMAN; REGULATORY MECHANISM; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0034819948     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916930108994125     Document Type: Article

References (25)

1. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse
2. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM
3. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
4. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
5. T helper cell subsets in insulin-dependent diabetes
6. High gradient magnetic cell separation with MACS
7. β-Cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice
8. T-cell mediated immune regulation
9. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/ H mice
10. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes
11. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells
12. Spontaneouse loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependant diabetes
13. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
14. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD (524-543)
15. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes
16. Glutamate decarboxylase and GABA in pancreatic islet: Lessons from knock-out mice
17. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology
18. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells
19. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice
20. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice
21. Suppressive effect on diabetes development in autoimmune diabetic mice by intramuscular injection of plasmid DNA expressing GAD and IL-4
22. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
23. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4
24. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-γ expression involved in the development of Th1 insulitis in NOD mice
25. In vivo anti-IL-18 monoclonal antibody treatment suppresses cyclophosphamide-induced diabetes in NOD mice